The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Phosphorylation of Thr 495 Regulates Ca 2+ /Calmodulin-Dependent Endothelial Nitric Oxide Synthase Activity
Abstract
Abstract —The activity of the endothelial nitric oxide synthase (eNOS) can be regulated independently of an increase in Ca 2+ by the phosphorylation of Ser 1177 but results only in a low nitric oxide (NO) output. In the present study, we assessed whether the agonist-induced (Ca 2+ -dependent, high-output) activation of eNOS is associated with changes in the phosphorylation of Thr 495 in the calmodulin (CaM)-binding domain. eNOS Thr 495 was constitutively phosphorylated in porcine aortic endothelial cells and was rapidly dephosphorylated after bradykinin stimulation. In the same cells, bradykinin enhanced the phosphorylation of Ser 1177 , which was maximal after 5 minutes, and abolished by the CaM-dependent kinase II (CaMKII) inhibitor KN-93. Bradykinin also enhanced the association of CaMKII with eNOS. Phosphorylation of Thr 495 was attenuated by the protein kinase C (PKC) inhibitor Ro 31-8220 and after PKC downregulation using phorbol 12-myristate 13-acetate. The agonist-induced dephosphorylation of Thr 495 was completely Ca 2+ -dependent and inhibited by the PP1 inhibitor calyculin A. Little CaM was bound to eNOS immunoprecipitated from unstimulated cells, but the agonist-induced dephosphorylation of Thr 495 enhanced the association of CaM. Mutation of Thr 495 to alanine increased CaM binding to eNOS in the absence of cell stimulation, whereas the corresponding Asp 495 mutant bound almost no CaM. Accordingly, NO production by the Ala 495 mutant was more sensitive to Ca 2+ /CaM than the aspartate mutant. These results suggest that the dual phosphorylation of Ser 1177 and Thr 495 determines the activity of eNOS in agonist-stimulated endothelial cells. Moreover, the dephosphorylation of Thr 495 by PP1 precedes the phosphorylation of Ser 1177 by CaMKII. The full text of this article is available at http://www.circresaha.org.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In resting endothelial cells, Thr495 is generally phosphorylated”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [297]
In the citing paper
“The phosphorylation has been attributed to protein kinase C (PKC) (297, 646), and the residue is dephosphorylated by protein phosphatase 1 (PP1)”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [297]
In the citing paper
“Phosphorylation of Thr495 is a negative regulator of CaM binding to eNOS (297, 407, 646).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [297]
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., & Zeiher, A. M. (1999) · Nature · doi:10.1038/21224 · Cited by 3,591
Self-citationCloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase
Bredt, D. S., Hwang, P. M., Glatt, C. E., Lowenstein, C. J., Reed, R. R., & Snyder, S. H. (1991) · Nature · doi:10.1038/351714a0 · Cited by 2,354
Dynamic activation of endothelial nitric oxide synthase by Hsp90
García‐Cardeña, G., Fan, R., Shah, V. H., Sorrentino, R., Cirino, G., Papapetropoulos, A., & Sessa, W. C. (1998) · Nature · doi:10.1038/33934 · Cited by 1,029
AMP‐activated protein kinase phosphorylation of endothelial NO synthase
Chen, Z.-P., Mitchelhill, K. I., Michell, B. J., Stapleton, D., Rodríguez‐Crespo, I., Witters, L. A., Power, D. A., de Montellano, P. R. O., & Kemp, B. E. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01705-0 · Cited by 839
Self-citationNishida, K., Harrison, D. G., Navas, J. P., Fisher, A. A., Dockery, S., Uematsu, M., Nerem, R. M., Alexander, R. W., & Murphy, T. J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116092 · Cited by 735
García‐Cardeña, G., Fan, R., Stern, D. F., Liu, J., & Sessa, W. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27237 · Cited by 533
Phosphorylation of Endothelial Nitric Oxide Synthase in Response to Fluid Shear Stress
Corson, M. A., James, N. L., Latta, S. E., Nerem, R. M., Berk, B. C., & Harrison, D. G. (1996) · Circulation Research · doi:10.1161/01.res.79.5.984 · Cited by 521
Calcium‐dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin
Busse, R., & Mülsch, A. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80902-u · Cited by 511
Self-citationMolecular cloning and characterization of human endothelial nitric oxide synthase
Marsden, P. A., Schappert, K. T., Chen, H. S., Flowers, M. A., Sundell, C. L., Wilcox, J. N., Lamas, S., & Michel, T. M. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80697-f · Cited by 489
Research works printed but not linked: 5
- 10.1161/hyp.25.2.180 · DOI
- 10.1161/res.79.5.984 · DOI
- 10.1161/res.82.6.686 · DOI
- Fulton D, Gratton J-P, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt [published correction appears in Nature. 1999;400:792]. Nature. 1999;399:597–601.
- 10.1161/res.78.5.750 · DOI
Cited by
Sorted by citations
Items 401–500 of 770
Heller, R., Hecker, M., Stahmann, N., Thiele, J. J., Werner‐Felmayer, G., & Werner, E. R. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.05.017 · Cited by 28
Kiss, L., Röder, Y., Bier, J., Weißmann, N., Seeger, W., & Grimminger, F. (2007) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-007-1718-9 · Cited by 28
Cale, J. M., & Bird, I. M. (2006) · Biochemical Journal · doi:10.1042/bj20060371 · Cited by 28
Novella, S., Laguna-Fernández, A., Lázaro‐Franco, M., Sobrino, A., Bueno‐Betí, C., Tarín, J. J., Monsalve, E., Sanchís, J., & Hermenegildo, C. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.08.020 · Cited by 28
“A possibility to explain this discrepancy is the concomitant raise in the inhibitory phosphorylation of eNOS on Thr495 as previously described (Fleming et al., 2001).”
Piazza, M. J., Taiakina, V., Guillemette, S. R., Guillemette, J. G., & Dieckmann, T. (2014) · Biochemistry · doi:10.1021/bi401466s · Cited by 28
Jagielska, J., Salguero, G., Schieffer, B., & Bavendiek, U. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.03.019 · Cited by 28
Hohmann, N., Xia, N., Steinkamp-Fenske, K., Förstermann, U., & Li, H. (2016) · Molecules · doi:10.3390/molecules21080973 · Cited by 27
“Stimuli such as shear stress, insulin, bradykinin, estrogen and HMG-CoA reductase inhibitors (‘statins’) that activate eNOS lead to phosphorylation of Ser1177 [14,42,43].”
Casin, K. M., & Kohr, M. J. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101441 · Cited by 27
“Phosphorylation of eNOS at threonine 495 by PKC in the absence of calmodulin, is known to be inhibitory [53].”
BackgroundAlpha1-adrenergic-mediated eNOS phosphorylation in intact arteries
Looft‐Wilson, R. C., Todd, S. E., Araj, C. A., Mutchler, S. M., & Goodell, C. R. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.09.003 · Cited by 27
“Phosphorylation of eNOS at Thr495 was less in all treatments relative to NT, but not significantly.”
BackgroundInfluentialTripterine prevents endothelial barrier dysfunction by inhibiting endogenous peroxynitrite formation
Wu, F. Y., Han, M. H., & Wilson, J. X. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00292.x · Cited by 27
“Therefore, tripterine may prevent the activation of eNOS that is associated with dephosphorylation of Thr495 (Fleming et al., 2001; Thomas et al., 2002).”
BackgroundCytochrome P450-dependent eicosanoid production and crosstalk
Fleming, I. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32834a9790 · Cited by 27
Self-citationPhylogenesis of constitutively formed nitric oxide in non-mammals
Toda, N., & Ayajiki, K. (2006) · Springer eBooks · doi:10.1007/112_0601 · Cited by 27
Zippel, N., Loot, A. E., Stingl, H., Randriamboavonjy, V., Fleming, I., & Fißlthaler, B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092753 · Cited by 27
Self-citationTheuer, J., Shagdarsuren, E., Müller, D. N., Kaergel, E., Honeck, H., Park, J.-K., Fiebeler, A., Dechend, R., Haller, H. G., Luft, F. C., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2005.00075.x · Cited by 27
David‐Dufilho, M., Brussel, E. M., Topal, G., Walch, L., Brunet, A., & Rendu, F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506374200 · Cited by 27
Cheng, P., Lu, P., Chen, S., Ho, W., Cheng, W., Hong, L., Yeh, T., Sun, G., Ling-lin, W., Hsiao, M., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01124.x · Cited by 26
“When the intracellular calcium concentration increases, the caveolin is displaced by calcium-calmodulin, which results in stimulation of phosphorylation at serine 1177 of the eNOS (Fleming et al., 2001).”
BackgroundE-cigarette effects on vascular function in animals and humans
Daiber, A., Kuntić, M., Oelze, M. W., Hahad, O., & Münzel, T. F. (2023) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-023-02813-z · Cited by 39
Park, J., Kim, W., Kim, J. Y., Park, M.-H., Nam, J., Yun, C., Kwon, Y., & Jo, I. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.021 · Cited by 26
Pham, T. H., Jin, S. W., Lee, G. H., Park, J. S., Kim, J. Y., Thai, T. N., Han, E. H., & Jeong, H. G. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b07909 · Cited by 26
Zhao, L., Li, J., Yuan, F., Li, M., Zhang, Q., Pang, J., Zhang, B., Sun, F., Sun, H., Li, Q., et al. (2015) · Marine Drugs · doi:10.3390/md13042306 · Cited by 27
“flux through the enzyme, thereby reducing the calcium requirement of eNOS and increasing NO production, making Ser-1177 a positive regulatory site [11,52]; conversely, the Thr-495 site serves as the negative regulatory site of eNOS activity by increasing calcium–calmodulin dependence of the enzyme [11,53].”
BackgroundAblation of iNOS delays cardiac contractile dysfunction in chronic hypertension
Wolska, B. M. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e92 · Cited by 25
“322 residue has been shown to decrease eNOS activity (46) and may potentiate the response to beta-adrenergic stimulation.”
BackgroundZhou, M., Widmer, R. J., Xie, W., Widmer, A. J., Miller, M. W., Schroeder, F., Parker, J. L., & Heaps, C. L. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00754.2009 · Cited by 25
Liu, J., Gao, Y., Negash, S., Longo, L. D., & Raj, J. U. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90333.2008 · Cited by 25
Xu, S., Li, X., LaPenna, K. B., Yokota, S. D., Huke, S., & He, P. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx021 · Cited by 26
Endothelial nitric oxide synthase is regulated by ERK phosphorylation at Ser602
Salerno, J. C., Ghosh, D. K., Razdan, R. K., Helms, K. A., Brown, C. C., McMurry, J. L., Rye, E. A., & Chrestensen, C. A. (2014) · Bioscience Reports · doi:10.1042/bsr20140015 · Cited by 25
Yoshitomi, H., Zhou, J., Nishigaki, T., Li, W., Liu, T., Wu, L., & Gao, M. (2020) · Phytotherapy Research · doi:10.1002/ptr.6685 · Cited by 24
Zhu, J., Angelov, S. N., Yildirim, I. A., Hao, W., Hu, J. H., Majesky, M. W., Brozovich, F. V., Kim, F., & Dichek, D. A. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.315878 · Cited by 26
Zaied, A. A., Ushio‐Fukai, M., Fukai, T., Kovács‐Kása, A., Alhusban, S., Varadarajan, S., Ganta, V. C., & Annex, B. H. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.027986 · Cited by 24
Frömel, T., & Fleming, I. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6150 · Cited by 24
Self-citationPott, C., Steinritz, D., Bölck, B., Mehlhorn, U., Brixius, K., Schwinger, R. H. G., & Bloch, W. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00005.2005 · Cited by 24
Kwok, W., Lee, S. H., Culberson, C., Korneszczuk, K., & Clemens, M. G. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00106.2009 · Cited by 24
Musicki, B., Champion, H. C., Hsu, L. L.-Y., Bivalacqua, T. J., & Burnett, A. L. “. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.02123.x · Cited by 24
Zhang, S., Guo, S., Gao, X., Liu, A., Jiang, W., Chen, X., Yang, P., Liu, L., Shi, L., & Zhang, Y. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14180 · Cited by 24
The effect of n-3 PUFA on eNOS activity and expression in Ea hy 926 cells
Gousset‐Dupont, A., Robert, V., Grynberg, A., Lacour, B., & Tardivel, S. (2007) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.11.005 · Cited by 24
Wang, J., Xu, Z., Kitajima, I., & Wang, Z. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.10.034 · Cited by 24
The risk of myocardial infarction in patients with reduced activity of cytochrome P450 2C9
Visser, L. E., van Schaik, R. H. N., Danser, A. H. J., Albert Hofman, D., Witteman, J. C. M., van Duijn, C. M., Uitterlinden, A. G., Pols, H. A. P., & Stricker, B. H. C. (2007) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000236335.57046.c8 · Cited by 23
Warboys, C. M., Chen, N., Zhang, Q., Shaifta, Y., Vanderslott, G., Passacquale, G., Hu, Y., Xu, Q., Ward, J. P. T., & Ferro, A. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu173 · Cited by 23
Tanabe, A., Shiraishi, M., Negishi, M., Saito, N., Tanabe, M., & Sasaki, Y. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22763 · Cited by 23
“The dephosphorylation of eNOS is induced by PP 1 (Fleming et al., 2001).”
BackgroundCale, J. M., & Bird, I. M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00942.2005 · Cited by 23
Saito, H., Godo, S., Sato, S., Ito, A., Ikumi, Y., Tanaka, S., Ida, T., Fujii, S., Akaike, T., & Shimokawa, H. (2017) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000552 · Cited by 23
Nitric oxide production by glomerular podocytes
Palygin, O., Ilatovskaya, D. V., Levchenko, V., Endres, B. T., Geurts, A. M., & Staruschenko, A. (2017) · Nitric Oxide · doi:10.1016/j.niox.2017.11.005 · Cited by 23
Blanco‐Rivero, J., Sagredo, A., Balfagón, G., & Ferrer, M. (2007) · Journal of Endocrinology · doi:10.1677/joe.1.07079 · Cited by 23
“…i.e. regulatory mechanisms other than PKC could be working on eNOS, including different redox conditions (Polytarchou & Papadimitriou 2005), phosphatase activity (Fleming et al. 2001) and/ or other kinases (Ferrer et al. 2004) that, in turn, regulate the intracellular environment and function.”
BackgroundTurovsky, E. A., Turovskaya, M. V., Долгачева, Л. П., Зинченко, В. П., & Dynnik, V. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063483 · Cited by 22
Spotlight on ROS and β 3-Adrenoreceptors Fighting in Cancer Cells
Calvani, M., Subbiani, A., Vignoli, M., & Favre, C. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6346529 · Cited by 24
Hu, S., Pi, Q., Xu, X., Yan, J., Guo, Y., Tan, W., He, A., Cheng, Z., Luo, S., & Xia, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118606 · Cited by 22
Zhou, X., Yuan, D., Wang, M., & He, P. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00300.2012 · Cited by 22
Protein Kinase C – Possible Therapeutic Target to Treat Cardiovascular Diseases
Bynagari, Y. S., Chari, R., Kilpatrick, L. E., & Kunapuli, S. P. (2010) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/187152910793743869 · Cited by 22
Koo, B., Hwang, H. M., Yi, B., Lim, H. K., Jeon, B. H., Hoe, K., Kwon, Y., Won, M., Kim, Y., Berkowitz, D. E., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009579 · Cited by 22
Daiber, A., Oelze, M. W., Daub, S., Steven, S., Schuff, A., Kröller‐Schön, S., Hausding, M., Wenzel, P., Schulz, E., Gori, T., et al. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_48 · Cited by 21
Taylor, S., Dixon, H. M., Yoganayagam, S., Price, N., & Lang, D. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.05.026 · Cited by 22
“Negative regulation occurs through increased eNOS phosphorylation at Ser114/6 (Li et al., 2007) and Thr495/7 (Fleming et al., 2001), while positive regulation occurs through increased phosphorylation at Ser633/5 and Ser1177/9 (Boo et al., 2003; Dimmeler et al., 1999; Fulton et al., 1999; McCabe et…”
BackgroundInfluentialMedhora, M. M., Narayanan, J., Harder, D. R., & Maier, K. G. (2001) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.86.369 · Cited by 22
PP2B-dependent NO production in the medullary thick ascending limb during diabetes
Foster, J. M., Carmines, P. K., & Pollock, J. S. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90760.2008 · Cited by 22
“In porcine aortic endothelial cells, CsA fails to affect phosphorylation of NOS3 at the Thr(495) and Ser(1177) sites (9).”
BackgroundTeichert-Kuliszewska, K., Tsoporis, J. N., Desjardins, J., Yin, J., Wang, L., Kuebler, W. M., & Parker, T. G. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu241 · Cited by 22
Redox Switches in Noise-Induced Cardiovascular and Neuronal Dysregulation
Frenis, K., Kuntić, M., Hahad, O., Jiménez, M. T. B., Oelze, M. W., Daub, S., Steven, S., Münzel, T. F., & Daiber, A. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.784910 · Cited by 22
“Increased eNOS phosphorylation at Frontiers in Molecular Biosciences | www.frontiersin.org November 2021 | Volume 8 | Article 7849107 Thr495 or Tyr657 in response to noise exposure was so far not reported but could be expected due to the redox-sensitivity of the kinases PKC and PYK-2 that confer these phosphorylations.”
BackgroundInfluentialBetrie, A. H., Ma, S., Ow, C. P. C., Peiris, R. M., Evans, R. G., Ayton, S., Lane, D. J. R., Southon, A. G., Bailey, S. R., Bellomo, R., et al. (2023) · Acta Physiologica · doi:10.1111/apha.14025 · Cited by 20
CaMKII, ‘jack of all trades’ in inflammation during cardiac ischemia/reperfusion injury
Zhang, W., Dong, E., Zhang, J., & Zhang, Y. (2023) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2023.10.003 · Cited by 21
Batori, R. K., Bécsi, B., Nagy, D., Kónya, Z., Hegedűs, C., Bordán, Z., Verin, A. D., Lontay, B., & Erdődi, F. (2017) · Scientific Reports · doi:10.1038/srep44698 · Cited by 24
Ferguson, S. K., Redinius, K. M., Yalamanoglu, A., Harral, J. W., Baek, J. H., Pak, D. I., Loomis, Z. L., Hassell, D., Eigenberger, P., Nozik‐Grayck, E., et al. (2018) · The Journal of Physiology · doi:10.1113/jp275810 · Cited by 21
“Conversely, AMP-activated kinase phosphorylates eNOS at threonine 495, leading to diminished activity of the enzyme (Fleming et al. 2001).”
BackgroundMazrouei, S., Sharifpanah, F., Caldwell, R. W., Franz, M., Shatanawi, A., Muessig, J. M., Fritzenwanger, M., Schulze, P. C., & Jung, C. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.05.004 · Cited by 21
Gomisin A induces Ca2+-dependent activation of eNOS in human coronary artery endothelial cells
Park, J. Y., Shin, H. K., Choi, Y. W., Lee, Y. J., Bae, S. S., Han, J., & Kim, C. D. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.06.028 · Cited by 21
“…al., 1997) and an Akt kinase-dependent erine phosphorylation of eNOS in position 1177 (i.e., Ser1177 eNOS) Michel et al., 1997; Fulton et al., 1999; Fleming et al., 2001). n the present study, we demonstrated that GA rapidly induced NOS translocation within 5 min after GA application with little…”
BackgroundCraps, J., Wilvers, C., Joris, V., Jongh, B. D., Vanderstraeten, J., Lobysheva, I. I., Balligand, J., Sonveaux, P., Gilon, P., Many, M., et al. (2014) · Endocrinology · doi:10.1210/en.2014-1729 · Cited by 21
Münzel, T. F. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01507-8 · Cited by 21
Koo, B., Won, M., Kim, Y., & Ryoo, S. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab163 · Cited by 20
Gaete, P. S., Lillo, M. A., Ardiles, N. M., Pérez, F. R., & Figueroa, X. F. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.036 · Cited by 20
Regulation of arterial blood pressure by Akt1-dependent vascular relaxation
Ha, J. M., Kim, Y. W., Lee, D. H., Yun, S. J., Kim, E. K., Jin, I. H., Kim, J. H., Kim, C. D., Shin, H. K., & Bae, S. S. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0798-3 · Cited by 20
“Calcium/ calmodulin-dependent protein kinase II and AMPactivated protein kinase increase eNOS activity by phosphorylation on Ser1177 [3, 4 ]. In addition, Ser1177 is phosphorylated by Akt protein kinase which plays a central role in survival, growth, differentiation, and proliferation [5–7].”
BackgroundKang, J. J., Shu, L., Park, J. L., Shayman, J. A., & Bodary, P. F. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00185.2013 · Cited by 20
Jin, S. W., Pham, H., Choi, J. H., Lee, G. H., Han, E. H., Cho, Y. H., Chung, Y. C., Kim, Y. H., & Jeong, H. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225772 · Cited by 19
Ikejima, H., Imanishi, T., Tsujioka, H., Kuroi, A., Muragaki, Y., Mochizuki, S., Goto, M., Yoshida, K., & Akasaka, T. (2008) · Circulation Journal · doi:10.1253/circj.72.998 · Cited by 19
Schmitt, C. A., Heiß, E. H., Aristei, Y., Severin, T., & Dirsch, V. M. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn326 · Cited by 19
Thai, T., Zhong, F., Dang, L., Chan, E., Ku, J., Malle, E., Geczy, C. L., Keaney, J. F., & Thomas, S. R. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.448 · Cited by 20
Thiebault, C., Ferrari, L., Boutherin‐Falson, O., Kockx, M. M., Desquand‐Billiald, S., Fichelle, J. M., Nottin, R., Renaud, J., Batt, A., & Visvikis‐Siest, S. (2004) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2004.03996.x · Cited by 19
Sedoris, K. C., Gozal, E., Ovechkin, A. V., Theile, A. R., & Roberts, A. M. (2011) · Acta Physiologica · doi:10.1111/j.1748-1716.2011.02348.x · Cited by 18
“Full activation requires its coupling with Thr495 dephosphorylation (Fleming et al. 2001, Michell et al. 2001; Li et al. 2004b).”
BackgroundNagane, M., Yasui, H., Sakai, Y., Yamamori, T., Niwa, K., Hattori, Y., Kondo, T., & Inanami, O. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.12.002 · Cited by 19
Fabin, N., Bergami, M., Cenko, E., Bugiardini, R., & Manfrini, O. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11051244 · Cited by 18
The Effects of Acidosis on eNOS in the Systemic Vasculature: A Focus on Early Postnatal Ontogenesis
Gaynullina, D. K., Tarasova, O. S., Shvetsova, A. A., Borzykh, A. A., & Schubert, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115987 · Cited by 18
“The kinase that phosphorylates eNOS at Thr495 is claimed to be protein kinase C (PKC); PKC inhibitors considerably increase the synthesis of NO [45].”
BackgroundCheng, P., Wu, A. T. H., Lu, P., Yang, Y., Ho, W., Lin, H., Hsiao, M., & Tseng, C. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02077.x · Cited by 18
“When the intracellular calcium concentration increases, caveolin is displaced by calciumcalmodulin, which results in stimulatory phosphorylation at Ser of eNOS (Fleming et al., 2001; Cheng et al., 2011).”
BackgroundJia, X.-Y., Xu, J., Gu, Y., Gu, X., Li, W., & Wang, Y. (2016) · Biology of Reproduction · doi:10.1093/biolre/bio142604 · Cited by 18
Park, J., Park, M., Byun, C. J., & Jo, I. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.11.112 · Cited by 18
Sasahara, T., Yayama, K., Matsuzaki, T., Tsutsui, M., & Okamoto, H. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.11.004 · Cited by 18
Cho, D., Choi, Y. J., Jo, S. A., Nam, J., Jung, S., & Jo, I. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.099 · Cited by 18
Kwok, W., & Clemens, M. G. (2014) · Shock · doi:10.1097/shk.0000000000000252 · Cited by 18
Tan, S.-E. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3280142636 · Cited by 18
“It is of interest to notice that neuronal NOS can be regulated via phosphorylation by CaM-kinase II (Komeima et al., 2000; Fleming et al., 2001; Agostino et al., 2004).”
BackgroundResultInvolvement of the proteasome in activation of endothelial nitric oxide synthase
Govers, R., de Bree, P., & Rabelink, T. J. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00644-1 · Cited by 18
John, T. A., Ibe, B. O., & Raj, J. U. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04801.x · Cited by 18
Ozawa, Y., Hayashi, K., Kanda, T., Homma, K., Takamatsu, I., Tatematsu, S., Yoshioka, K., Kumagai, H., Wakino, S., & Saruta, T. (2004) · Nephrology · doi:10.1111/j.1440-1797.2004.00292.x · Cited by 18
Damacena de Angelis, C., Endoni, B. T., Nuno, D., Lamping, K., Ledolter, J., Koval, O. M., & Grumbach, I. M. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.023912 · Cited by 17
Silva, B. R., Pernomian, L., Grando, M. D., & Bendhack, L. M. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.05.040 · Cited by 17
Hwang, S., Lee, H.-J., Kim, G., Won, K., Park, Y. S., & Jo, I. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.08.005 · Cited by 18
GPER inhibits diabetes-mediated RhoA activation to prevent vascular endothelial dysfunction
Li, Z., Cheng, L., Liang, H., Duan, W., Hu, J., Zhi, W., Yang, J., Liu, Z., Zhao, M., & Liu, J. (2015) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2015.12.002 · Cited by 17
“Subsequent phosphorylation of the stimulatory site Ser1177 optimizes eNOS activity (Fleming et al., 2001; Mount et al., 2007).”
BackgroundMorikawa, Y., Shibata, A., Okumura, N., Ikari, A., Sasajima, Y., Suenami, K., Sato, K., Takekoshi, Y., El-Kabbani, O. A. L., & Matsunaga, T. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.11.003 · Cited by 17
Balla, Z., Hoch, B., Karczewski, P., & Blasig, I. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200553200 · Cited by 17
Therapeutic potential of targeting the renin angiotensin system in portal hypertension
Herath, C. B. (2013) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v4.i1.1 · Cited by 17
DT-13 ameliorates TNF-α-induced nitric oxide production in the endothelium in vivo and in vitro
Fan, R., Han, Y., Han, H., Chen, Z., Yu, B., Kou, J., & Zhang, Y. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.009 · Cited by 17
Ruan, L., Torres, C. M., Buffett, R. J., Kennard, S., Fulton, D. J., & Venema, R. C. (2013) · Vascular Pharmacology · doi:10.1016/j.vph.2013.05.004 · Cited by 17
“Agonist- and flow-stimulated phosphorylation at S1179, for example, increases eNOS activity (Fulton et al., 1999; Dimmeler et al., 1999) whereas phosphorylation at T497 reduces enzyme activity (Harris et al., 2001b; Fleming et al., 2001; Michell et al., 2001).”
BackgroundChiang, T. M., Woo-Rasberry, V., & Cole, F. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00311-7 · Cited by 17
Cardenas, H. L., Evanoff, N. G., Fandl, H. K., Berry, A. R., Wegerson, K. N., Ostrander, E. I., Greiner, J. J., Dufresne, S. R., Kotlyar, M., Dengel, D. R., et al. (2023) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00243.2023 · Cited by 16
Haendeler, J., Mlynek, A., Büchner, N., Lukosz, M., Graf, M. R., Guettler, C., Jakob, S., Farrokh, S., Kunze, K., Goy, C., et al. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301428 · Cited by 16
Seo, J., Lee, J. Y., Sung, M.-S., Byun, C. J., Cho, D., Lee, H.-J., Park, J., Cho, H.-S., Cho, S.-J., & Jo, I. (2014) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2014.106 · Cited by 16
“Previously, PP1, PP2A or PKC was reported to be involved in alteration in eNOS-Thr497 phosphorylation (Fleming et al., 2001; Michell et al., 2001).”
BackgroundSomatostatin modulates PI3K-Akt, eNOS and NHE activity in the ciliary epithelium
Ghosh, S., Choritz, L., Geibel, J. P., & Coca‐Prados, M. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.05.002 · Cited by 16
Modulation of endothelial nitric oxide synthase by fibronectin
Viji, R. I., Kumar, V. B. S., Kiran, M. S., & Sudhakaran, P. R. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9967-2 · Cited by 16
Metadata
- Authors
- Fleming, I., Fisslthaler, B., Dimmeler, S., Kemp, B. E., & Busse, R.
- Affiliations
- Goethe University Frankfurt (DE)
- Venue
- Circulation Research
- Published
- 2001-06-08
- Volume
- 88
- Issue
- 11
- Pages
- E68-75
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2135297555
- Cited by
- 770
- References
- 38
- Citations by year
- 2026: 12 · 2025: 25 · 2024: 13 · 2023: 17 · 2022: 17 · 2021: 23 · 2020: 18 · 2019: 23 · 2018: 18 · 2017: 29 · 2016: 30 · 2015: 39 · 2014: 34 · 2013: 28 · 2012: 49
- FWCI
- 23.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart Foundation of Australia
- Deutsche Forschungsgemeinschaft (SFB 553)
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- endothelial nitric oxide synthase, calmodulin binding, CaMKII, PP1 phosphatase, calyculin A, bradykinin, protein kinase C, nitric oxide production, endothelial cells, dual phosphorylation, calmodulin-dependent kinase II, calmodulin
- MeSH terms
- Animals, Binding Sites, Bradykinin, Calcium, Calmodulin, Cells, Cultured, Coronary Vessels, Endothelium, Vascular, Enzyme Activation, Enzyme Inhibitors, Humans, Phosphorylation, Precipitin Tests, Protein Kinase C, Proto-Oncogene Proteins, Swine, Threonine, Blotting, Western, Mutagenesis, Site-Directed, Protein Serine-Threonine Kinases, Calcium-Calmodulin-Dependent Protein Kinases, Nitric Oxide Synthase, Mitogen-Activated Protein Kinases, Proto-Oncogene Proteins c-akt, Nitric Oxide Synthase Type III, Calcium-Calmodulin-Dependent Protein Kinase Type 2, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review